Patients with
hypertension and
hyperaldosteronism show an increased risk of
stroke compared with patients with
essential hypertension. Aim of the study was to assess the effects of
aldosterone on left atrial function in rats as a potential contributor to
thromboembolism. Osmotic mini-pumps delivering 1.5 μg
aldosterone/h were implanted in rats subcutaneously (Aldo, n = 39; controls, n = 38). After 8 wk, left ventricular pressure-volume analysis of isolated working hearts was performed, and left atrial systolic and diastolic function was also assessed by atrial pressure-diameter loops. Moreover, left atrial myocytes were isolated to investigate their global and local Ca2+ handling and contractility. At similar heart rates, pressure-volume analysis of isolated hearts and in vivo hemodynamic measurements revealed neither systolic nor diastolic
left ventricular dysfunction in Aldo. In particular, atrial filling pressures and atrial size were not increased in Aldo. Aldo rats showed a significant reduction of atrial late diastolic A wave, atrial active work index, and increased V waves. Consistently, in Aldo rats, sarcomere shortening and the amplitude of electrically evoked global Ca2+ transients were substantially reduced. Sarcoplasmic reticulum-Ca2+ content and fractional Ca2+ release were decreased, substantiated by a reduced
sarcoplasmic reticulum calcium ATPase activity, resulting from a reduced
CAMKII-evoked phosphorylation of
phospholamban.
Hyperaldosteronism induced atrial systolic and diastolic dysfunction, while atrial size and left ventricular hemodynamics, including filling pressures, were unaffected in rats. The described model suggests a direct causal link between
hyperaldosteronism and decreased atrial contractility and diastolic compliance.